| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | MKRN4P FOXO1 ATXN7 ASXL3 KAT8 MAZ ARX SMARCC1 POU4F1 ASXL2 CHD4 CHD7 PBX2 KLF4 KDM6A HNRNPD RXRB | 2.85e-08 | 739 | 90 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXO1 FOXD3 FOXQ1 NKX2-1 MAZ ARX FOXB2 SP9 NR4A3 POU4F1 ZBTB12 CHD7 ZNF395 SIX4 PBX1 PBX2 KLF4 KDM6A RXRB EVX2 THAP11 | 1.11e-07 | 1244 | 90 | 21 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXO1 FOXD3 FOXQ1 NKX2-1 MAZ ARX FOXB2 SP9 NR4A3 POU4F1 ZBTB12 CHD7 ZNF395 SIX4 PBX1 PBX2 KLF4 KDM6A RXRB EVX2 THAP11 | 1.59e-07 | 1271 | 90 | 21 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXO1 FOXD3 FOXQ1 NKX2-1 MAZ ARX FOXB2 SP9 NR4A3 POU4F1 ZBTB12 CHD7 ZNF395 SIX4 PBX1 PBX2 KLF4 KDM6A RXRB CASZ1 EVX2 THAP11 | 3.67e-07 | 1459 | 90 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXO1 FOXD3 FOXQ1 NKX2-1 MAZ ARX FOXB2 SP9 NR4A3 POU4F1 ZBTB12 ZNF395 SIX4 PBX1 PBX2 KLF4 RXRB CASZ1 CREBZF EVX2 THAP11 | 9.00e-07 | 1412 | 90 | 21 | GO:0000981 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXO1 NKX2-1 ARX NR4A3 POU4F1 ZNF395 SIX4 PBX1 PBX2 KLF4 RXRB CASZ1 THAP11 | 1.32e-06 | 560 | 90 | 13 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXO1 NKX2-1 ARX NR4A3 POU4F1 ZNF395 SIX4 PBX1 PBX2 KLF4 RXRB CASZ1 THAP11 | 1.48e-06 | 566 | 90 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 1.42e-05 | 11 | 90 | 3 | GO:0005247 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.10e-05 | 140 | 90 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 5.75e-05 | 17 | 90 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.09e-04 | 167 | 90 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 1.99e-04 | 5 | 90 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.89e-04 | 582 | 90 | 10 | GO:0140297 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 5.40e-04 | 83 | 90 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | transcription factor binding | FOXO1 NKX2-1 KAT8 NR4A3 POU4F1 CHD4 PBX1 PBX2 KLF4 HIF1AN RXRB | 5.64e-04 | 753 | 90 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 5.89e-04 | 417 | 90 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 6.09e-04 | 320 | 90 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 6.80e-04 | 326 | 90 | 7 | GO:0001217 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 9.70e-04 | 562 | 90 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.40e-03 | 182 | 90 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.47e-03 | 184 | 90 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NKX2-1 KAT8 SUN1 HELZ2 SHARPIN SMARCC1 CHD4 KDM7A CNTLN KLF4 HIF1AN RXRB SAP30 | 2.04e-03 | 1160 | 90 | 13 | GO:0030674 |
| GeneOntologyMolecularFunction | snRNP binding | 2.31e-03 | 16 | 90 | 2 | GO:0070990 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulator activity | 2.93e-03 | 18 | 90 | 2 | GO:0035014 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.16e-03 | 65 | 90 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | antiporter activity | 3.53e-03 | 138 | 90 | 4 | GO:0015297 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXO1 FOXD3 NKX2-1 ATXN7 ASXL3 KAT8 MAZ ARX HELZ2 SMARCC1 NR4A3 POU4F1 ASXL2 CHD7 ZNF395 SIX4 PBX1 PBX2 KLF4 KDM6A HNRNPD RXRB CASZ1 CREBZF AGAP2 THAP11 | 1.21e-10 | 1390 | 90 | 26 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXO1 CDKN1C FOXD3 FOXQ1 NKX2-1 KAT8 MAZ ARX NR4A3 POU4F1 ZBTB12 ASXL2 CHD4 SIX4 KLF4 HIF1AN SAP30 CREBZF THAP11 | 7.73e-06 | 1399 | 90 | 19 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXO1 CDKN1C FOXD3 FOXQ1 NKX2-1 KAT8 MAZ ARX NR4A3 POU4F1 ZBTB12 ASXL2 CHD4 SIX4 KLF4 HIF1AN SAP30 CREBZF THAP11 | 8.91e-06 | 1413 | 90 | 19 | GO:1902679 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | FOXO1 CDKN1C FOXD3 FOXQ1 NKX2-1 MAZ ARX NR4A3 POU4F1 ZBTB12 ASXL2 CHD4 KLF4 SAP30 THAP11 | 4.73e-05 | 1053 | 90 | 15 | GO:0000122 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | CDKN1C AMOT SP9 NR4A3 ASXL2 CHD7 SIX4 PBX1 MYO15A PBX2 KLF4 KDM6A | 6.16e-05 | 713 | 90 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | globus pallidus development | 1.12e-04 | 4 | 90 | 2 | GO:0021759 | |
| GeneOntologyCellularComponent | chromatin | FOXO1 FOXD3 FOXQ1 NKX2-1 ATXN7 KAT8 ARX FOXB2 SMARCC1 SP9 NR4A3 POU4F1 CHD4 CHD7 SIX4 PBX1 PBX2 KLF4 HNRNPD RXRB CASZ1 SAP30 CREBZF EVX2 THAP11 | 1.91e-09 | 1480 | 90 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | FOXD3 NKX2-1 ATXN7 NR4A3 POU4F1 CHD4 SIX4 PBX1 PBX2 KLF4 RXRB CREBZF THAP11 | 1.59e-06 | 596 | 90 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ATXN7 AMOT ASXL3 KAT8 SUN1 RBM42 SMARCC1 POU4F1 ASXL2 CHD4 PBX1 SNRPB KDM6A SNRPN RXRB SAP30 CREBZF THAP11 | 1.96e-05 | 1377 | 90 | 18 | GO:0140513 |
| GeneOntologyCellularComponent | PR-DUB complex | 1.09e-04 | 4 | 90 | 2 | GO:0035517 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.74e-04 | 272 | 90 | 7 | GO:0090575 | |
| Domain | Cl-channel_core | 9.20e-06 | 9 | 91 | 3 | IPR014743 | |
| Domain | - | 9.20e-06 | 9 | 91 | 3 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 9.20e-06 | 9 | 91 | 3 | PF00654 | |
| Domain | Cl-channel_volt-gated | 9.20e-06 | 9 | 91 | 3 | IPR001807 | |
| Domain | Chromo/shadow_dom | 1.94e-05 | 33 | 91 | 4 | IPR000953 | |
| Domain | CHROMO | 1.94e-05 | 33 | 91 | 4 | SM00298 | |
| Domain | snRNP-assoc_SmB/SmN | 2.35e-05 | 2 | 91 | 2 | IPR017131 | |
| Domain | Homeobox_CS | 3.47e-05 | 186 | 91 | 7 | IPR017970 | |
| Domain | CBS | 5.98e-05 | 16 | 91 | 3 | SM00116 | |
| Domain | HARE-HTH | 7.02e-05 | 3 | 91 | 2 | PF05066 | |
| Domain | ASXH | 7.02e-05 | 3 | 91 | 2 | PF13919 | |
| Domain | PHD_3 | 7.02e-05 | 3 | 91 | 2 | PF13922 | |
| Domain | ASX-like_PHD | 7.02e-05 | 3 | 91 | 2 | IPR026905 | |
| Domain | ASX/ASX-like | 7.02e-05 | 3 | 91 | 2 | IPR024811 | |
| Domain | ASXH | 7.02e-05 | 3 | 91 | 2 | IPR028020 | |
| Domain | HB1/Asxl_HTH | 7.02e-05 | 3 | 91 | 2 | IPR007759 | |
| Domain | - | 7.21e-05 | 283 | 91 | 8 | 1.10.10.60 | |
| Domain | TF_fork_head_CS_2 | 7.36e-05 | 46 | 91 | 4 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 8.01e-05 | 47 | 91 | 4 | IPR018122 | |
| Domain | FH | 9.45e-05 | 49 | 91 | 4 | SM00339 | |
| Domain | FORK_HEAD_1 | 9.45e-05 | 49 | 91 | 4 | PS00657 | |
| Domain | FORK_HEAD_2 | 9.45e-05 | 49 | 91 | 4 | PS00658 | |
| Domain | Fork_head_dom | 9.45e-05 | 49 | 91 | 4 | IPR001766 | |
| Domain | FORK_HEAD_3 | 9.45e-05 | 49 | 91 | 4 | PS50039 | |
| Domain | Forkhead | 9.45e-05 | 49 | 91 | 4 | PF00250 | |
| Domain | CBS_dom | 1.20e-04 | 20 | 91 | 3 | IPR000644 | |
| Domain | CBS | 1.20e-04 | 20 | 91 | 3 | PF00571 | |
| Domain | CBS | 1.20e-04 | 20 | 91 | 3 | PS51371 | |
| Domain | PBC | 1.40e-04 | 4 | 91 | 2 | PF03792 | |
| Domain | PBX | 1.40e-04 | 4 | 91 | 2 | IPR005542 | |
| Domain | Homeobox | 1.47e-04 | 234 | 91 | 7 | PF00046 | |
| Domain | HOMEOBOX_1 | 1.55e-04 | 236 | 91 | 7 | PS00027 | |
| Domain | HOX | 1.59e-04 | 237 | 91 | 7 | SM00389 | |
| Domain | HOMEOBOX_2 | 1.67e-04 | 239 | 91 | 7 | PS50071 | |
| Domain | Homeobox_dom | 1.67e-04 | 239 | 91 | 7 | IPR001356 | |
| Domain | Homeodomain-like | 2.16e-04 | 332 | 91 | 8 | IPR009057 | |
| Domain | CHROMO_1 | 3.36e-04 | 28 | 91 | 3 | PS00598 | |
| Domain | CHROMO_2 | 3.36e-04 | 28 | 91 | 3 | PS50013 | |
| Domain | JMJC | 5.01e-04 | 32 | 91 | 3 | PS51184 | |
| Domain | Chromodomain-like | 5.01e-04 | 32 | 91 | 3 | IPR016197 | |
| Domain | JmjC_dom | 5.01e-04 | 32 | 91 | 3 | IPR003347 | |
| Domain | JmjC | 5.49e-04 | 33 | 91 | 3 | SM00558 | |
| Domain | WHTH_DNA-bd_dom | 1.18e-03 | 242 | 91 | 6 | IPR011991 | |
| Domain | ZF_PHD_2 | 1.20e-03 | 95 | 91 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 1.24e-03 | 96 | 91 | 4 | PS01359 | |
| Domain | Pept_M10A_stromelysin-type | 3.41e-03 | 18 | 91 | 2 | IPR016293 | |
| Domain | Sm | 3.80e-03 | 19 | 91 | 2 | SM00651 | |
| Domain | LSM | 3.80e-03 | 19 | 91 | 2 | PF01423 | |
| Domain | LSM_dom_euk/arc | 3.80e-03 | 19 | 91 | 2 | IPR001163 | |
| Domain | PG_binding_1 | 4.21e-03 | 20 | 91 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 4.21e-03 | 20 | 91 | 2 | IPR002477 | |
| Domain | - | 4.27e-03 | 218 | 91 | 5 | 1.10.10.10 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO1 FOXD3 FOXQ1 MAP1B SERPINB3 COP1 SMARCC1 ASXL2 CHD4 SIX4 RSRC2 PBX1 PBX2 HIF1AN RXRB CASZ1 SAP30 NOVA2 | 8.24e-12 | 857 | 91 | 18 | 25609649 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO1 FOXD3 FOXQ1 NKX2-1 MAZ ARX SP9 NR4A3 POU4F1 ZNF395 SIX4 PBX1 PBX2 KLF4 RXRB CREBZF EVX2 THAP11 | 2.12e-11 | 908 | 91 | 18 | 19274049 |
| Pubmed | MKRN4P FOXO1 FOXD3 NKX2-1 PCSK6 SMARCC1 NR4A3 CHD4 SIX4 PBX1 PBX2 KLF4 RNF115 RXRB EVX2 | 4.93e-10 | 709 | 91 | 15 | 22988430 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | IRS4 AMOT MAZ SLTM COP1 SMARCC1 PUM2 CHD4 CHD7 PBX1 PBX2 HNRNPD | 8.61e-10 | 411 | 91 | 12 | 35182466 |
| Pubmed | IRS4 FOXQ1 ATXN7 KAT8 MAZ COP1 SMARCC1 PUM2 SP9 ASXL2 CHD7 SIX4 PBX1 PBX2 KLF4 KDM6A SLC1A5 THAP11 | 2.74e-08 | 1429 | 91 | 18 | 35140242 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KAT8 MAZ RBM42 SLTM SMARCC1 ASXL2 CHD4 CHD7 ZNF395 SIX4 KLF4 KDM6A SNRPN HNRNPD CASZ1 SAP30 CLASRP | 3.85e-08 | 1294 | 91 | 17 | 30804502 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | IRS4 SERPINB3 MAZ SMARCC1 CHD4 CHD7 SIX4 PBX1 PBX2 SNRPB SLC1A5 SAP30 | 4.17e-08 | 583 | 91 | 12 | 29844126 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PNPT1 NPTX2 MAP1B MAZ HELZ2 RBM42 SLTM SMARCC1 CHD4 CHD7 RSRC2 SNRPB HNRNPD MARCKS THAP11 | 1.35e-07 | 1082 | 91 | 15 | 38697112 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.90e-07 | 544 | 91 | 11 | 28473536 | |
| Pubmed | Genome-wide atlas of gene expression in the adult mouse brain. | 3.14e-07 | 54 | 91 | 5 | 17151600 | |
| Pubmed | 4.13e-07 | 57 | 91 | 5 | 21122108 | ||
| Pubmed | Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants. | 5.32e-07 | 25 | 91 | 4 | 23042297 | |
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 1.44e-06 | 9 | 91 | 3 | 23115349 | |
| Pubmed | 1.87e-06 | 77 | 91 | 5 | 21525287 | ||
| Pubmed | Ion channel expression in the developing enteric nervous system. | 2.71e-06 | 37 | 91 | 4 | 25798587 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.08e-06 | 351 | 91 | 8 | 38297188 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CLCN7 OBSCN HELZ2 PALM ZNF395 KLF4 MMP17 SLC1A5 CASZ1 SAP30 RYR1 FAM83H THAP11 | 6.06e-06 | 1105 | 91 | 13 | 35748872 |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16129671 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 8510173 | ||
| Pubmed | COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression. | 6.77e-06 | 2 | 91 | 2 | 18815134 | |
| Pubmed | Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. | 6.77e-06 | 2 | 91 | 2 | 16034421 | |
| Pubmed | Concerted regulation and molecular evolution of the duplicated SNRPB'/B and SNRPN loci. | 6.77e-06 | 2 | 91 | 2 | 10556313 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 7910944 | ||
| Pubmed | PCSK6 exacerbates Alzheimer's disease pathogenesis by promoting MT5-MMP maturation. | 6.77e-06 | 2 | 91 | 2 | 38216110 | |
| Pubmed | Transcriptional repression of FOXO1 by KLF4 contributes to glioma progression. | 6.77e-06 | 2 | 91 | 2 | 27835585 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 10471807 | ||
| Pubmed | UTX mediates demethylation of H3K27me3 at muscle-specific genes during myogenesis. | 6.77e-06 | 2 | 91 | 2 | 20300060 | |
| Pubmed | Pbx1 is required for adult subventricular zone neurogenesis. | 6.77e-06 | 2 | 91 | 2 | 27226325 | |
| Pubmed | KLF4 suppresses HDACi induced caspase activation and the SAPK pathway by targeting p57(Kip2). | 6.77e-06 | 2 | 91 | 2 | 19544095 | |
| Pubmed | TIF1beta/KAP-1 is a coactivator of the orphan nuclear receptor NGFI-B/Nur77. | 7.71e-06 | 15 | 91 | 3 | 19321449 | |
| Pubmed | 9.47e-06 | 16 | 91 | 3 | 28603487 | ||
| Pubmed | 1.44e-05 | 300 | 91 | 7 | 28561026 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FOXQ1 NKX2-1 NR4A3 POU4F1 CHD4 PBX1 PBX2 HIF1AN HNRNPD RXRB SAP30 | 1.86e-05 | 877 | 91 | 11 | 20211142 |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.91e-05 | 20 | 91 | 3 | 29785026 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 9256467 | ||
| Pubmed | KLF4 and PBX1 directly regulate NANOG expression in human embryonic stem cells. | 2.03e-05 | 3 | 91 | 2 | 19522013 | |
| Pubmed | The TALE homeodomain protein Pbx2 is not essential for development and long-term survival. | 2.03e-05 | 3 | 91 | 2 | 15169896 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 32125007 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 30792202 | ||
| Pubmed | Genome-wide association between Six4, MyoD, and the histone demethylase Utx during myogenesis. | 2.03e-05 | 3 | 91 | 2 | 26229056 | |
| Pubmed | Cooperative transcriptional activation by Klf4, Meis2, and Pbx1. | 2.03e-05 | 3 | 91 | 2 | 21746878 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 10679934 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 12609849 | ||
| Pubmed | An alternative mechanism of clathrin-coated pit closure revealed by ion conductance microscopy. | 2.03e-05 | 3 | 91 | 2 | 22564416 | |
| Pubmed | STK40 inhibits trophoblast fusion by mediating COP1 ubiquitination to degrade P57Kip2. | 2.03e-05 | 3 | 91 | 2 | 39304928 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 17897615 | ||
| Pubmed | Lysosomal degradation of endocytosed proteins depends on the chloride transport protein ClC-7. | 2.03e-05 | 3 | 91 | 2 | 19661288 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 16412590 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 10640822 | ||
| Pubmed | A comparison of snRNP-associated Sm-autoantigens: human N, rat N and human B/B'. | 2.03e-05 | 3 | 91 | 2 | 2522186 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 25835095 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 11468159 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 9482739 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 33751773 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 7744014 | ||
| Pubmed | IRS4 CLCN4 CLCN5 MAP1B ATXN7 RBM42 SMARCC1 PALM CHD4 KLF4 SNRPB SNRPN HNRNPD AGAP2 | 2.24e-05 | 1442 | 91 | 14 | 35575683 | |
| Pubmed | 2.81e-05 | 134 | 91 | 5 | 19030180 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 2.91e-05 | 135 | 91 | 5 | 31077711 | |
| Pubmed | Identification and characterisation of imprinted genes in the mouse. | 2.95e-05 | 23 | 91 | 3 | 15163367 | |
| Pubmed | Sp9 Regulates Medial Ganglionic Eminence-Derived Cortical Interneuron Development. | 3.37e-05 | 24 | 91 | 3 | 29878134 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 3.43e-05 | 232 | 91 | 6 | 25515538 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN7 HELZ2 SMARCC1 PUM2 CHD4 CHD7 KDM6A HNRNPD SAP30 CLASRP | 3.57e-05 | 774 | 91 | 10 | 15302935 |
| Pubmed | PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. | 4.05e-05 | 4 | 91 | 2 | 17986608 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 7670497 | ||
| Pubmed | Different chromosomal localization of the Clcn4 gene in Mus spretus and C57BL/6J mice. | 4.05e-05 | 4 | 91 | 2 | 7670496 | |
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 4.05e-05 | 4 | 91 | 2 | 34536441 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 20351103 | ||
| Pubmed | PBX1 acts as terminal selector for olfactory bulb dopaminergic neurons. | 4.05e-05 | 4 | 91 | 2 | 32156753 | |
| Pubmed | Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. | 4.05e-05 | 4 | 91 | 2 | 17110406 | |
| Pubmed | Pbx/Meis deficiencies demonstrate multigenetic origins of congenital heart disease. | 4.05e-05 | 4 | 91 | 2 | 18723445 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 34374074 | ||
| Pubmed | Mutational analysis of CLC-5, cofilin and CLC-4 in patients with Dent's disease. | 4.05e-05 | 4 | 91 | 2 | 19546591 | |
| Pubmed | PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1. | 4.05e-05 | 4 | 91 | 2 | 1682799 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 8661110 | ||
| Pubmed | 5.11e-05 | 808 | 91 | 10 | 20412781 | ||
| Pubmed | 5.41e-05 | 28 | 91 | 3 | 32868762 | ||
| Pubmed | PNPT1 MAZ PCSK6 HELZ2 RBM42 SMARCC1 CHD4 CHD7 RSRC2 SNRPB SLC1A5 MARCKS THAP11 | 5.77e-05 | 1371 | 91 | 13 | 36244648 | |
| Pubmed | 6.03e-05 | 29 | 91 | 3 | 29543863 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 18973687 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 24337315 | ||
| Pubmed | Transcription factor PBX4 regulates limb development and haematopoiesis in mice. | 6.74e-05 | 5 | 91 | 2 | 38230761 | |
| Pubmed | The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus. | 6.74e-05 | 5 | 91 | 2 | 18362360 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 10842069 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 12661033 | ||
| Pubmed | Pbx4, a new Pbx family member on mouse chromosome 8, is expressed during spermatogenesis. | 6.74e-05 | 5 | 91 | 2 | 11335119 | |
| Pubmed | HOXA9 forms triple complexes with PBX2 and MEIS1 in myeloid cells. | 6.74e-05 | 5 | 91 | 2 | 10082572 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 19339555 | ||
| Pubmed | 6.88e-05 | 83 | 91 | 4 | 28794006 | ||
| Pubmed | 7.39e-05 | 31 | 91 | 3 | 25996949 | ||
| Pubmed | 7.63e-05 | 268 | 91 | 6 | 33640491 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 8.64e-05 | 398 | 91 | 7 | 35016035 | |
| Pubmed | A multipotent progenitor domain guides pancreatic organogenesis. | 9.85e-05 | 91 | 91 | 4 | 17609113 | |
| Pubmed | An ikaros-containing chromatin-remodeling complex in adult-type erythroid cells. | 1.01e-04 | 6 | 91 | 2 | 11003653 | |
| Pubmed | Expression of CLCN voltage-gated chloride channel genes in human blood vessels. | 1.01e-04 | 6 | 91 | 2 | 10198195 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 19559479 | ||
| Pubmed | The PBX-regulating protein PREP1 is present in different PBX-complexed forms in mouse. | 1.01e-04 | 6 | 91 | 2 | 10381567 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 36108220 | ||
| Pubmed | Characterization of TALE genes expression during the first lineage segregation in mammalian embryos. | 1.01e-04 | 6 | 91 | 2 | 22987645 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 21095589 | ||
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 18218983 | ||
| Interaction | FOXK2 interactions | 7.41e-07 | 225 | 90 | 9 | int:FOXK2 | |
| Interaction | TBX5 interactions | 4.90e-06 | 150 | 90 | 7 | int:TBX5 | |
| Interaction | HCFC1 interactions | 6.47e-06 | 293 | 90 | 9 | int:HCFC1 | |
| Interaction | CIC interactions | IRS4 FOXQ1 SERPINB3 MAZ SMARCC1 CHD4 CHD7 SIX4 PBX1 PBX2 SNRPB SLC1A5 SAP30 | 8.84e-06 | 673 | 90 | 13 | int:CIC |
| Interaction | TLX1 interactions | 1.35e-05 | 175 | 90 | 7 | int:TLX1 | |
| Interaction | TBL1XR1 interactions | 2.45e-05 | 192 | 90 | 7 | int:TBL1XR1 | |
| Interaction | HOXC12 interactions | 3.03e-05 | 14 | 90 | 3 | int:HOXC12 | |
| Interaction | MAB21L1 interactions | 3.03e-05 | 14 | 90 | 3 | int:MAB21L1 | |
| Interaction | SATB2 interactions | 7.91e-05 | 159 | 90 | 6 | int:SATB2 | |
| Interaction | MTAP interactions | 8.56e-05 | 100 | 90 | 5 | int:MTAP | |
| Interaction | GATA4 interactions | 9.19e-05 | 411 | 90 | 9 | int:GATA4 | |
| GeneFamily | Chloride voltage-gated channels | 4.53e-06 | 10 | 62 | 3 | 302 | |
| GeneFamily | Forkhead boxes | 1.40e-05 | 43 | 62 | 4 | 508 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 3.04e-03 | 24 | 62 | 2 | 891 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.04e-03 | 24 | 62 | 2 | 485 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 3.57e-03 | 26 | 62 | 2 | 526 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP | 1.28e-06 | 99 | 91 | 6 | M768 | |
| Coexpression | BENPORATH_EED_TARGETS | GPR6 FOXD3 NPTX2 FOXQ1 CLCN5 RASGRF1 NKX2-1 SPOCK3 AMOT NR4A3 CRTAC1 POU4F1 LONRF3 KLF4 CASZ1 | 3.49e-06 | 1059 | 91 | 15 | M7617 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | CDKN1C NPTX2 IRS4 FOXQ1 RASGRF1 ARX PKIB SP9 CRTAC1 TACR3 SIX4 NRG3 KLF4 SLC1A5 CASZ1 | 4.14e-06 | 1074 | 91 | 15 | M1941 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 4.90e-06 | 363 | 91 | 9 | M41103 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | GPR6 FOXD3 FOXQ1 CLCN5 RASGRF1 NKX2-1 SPOCK3 NR4A3 CRTAC1 POU4F1 LONRF3 KLF4 CASZ1 NOVA2 AGAP2 | 6.51e-06 | 1115 | 91 | 15 | M10371 |
| Coexpression | BENPORATH_SUZ12_TARGETS | FOXD3 IRS4 CLCN5 RASGRF1 NKX2-1 SPOCK3 AMOT NHS NR4A3 CRTAC1 POU4F1 LONRF3 KLF4 CASZ1 | 1.29e-05 | 1035 | 91 | 14 | M9898 |
| Coexpression | BENPORATH_PRC2_TARGETS | FOXD3 CLCN5 RASGRF1 NKX2-1 SPOCK3 NR4A3 CRTAC1 POU4F1 LONRF3 KLF4 CASZ1 | 1.57e-05 | 650 | 91 | 11 | M8448 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 3.03e-05 | 350 | 91 | 8 | M1949 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 3.48e-05 | 357 | 91 | 8 | MM828 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP | 6.37e-05 | 196 | 91 | 6 | M4423 | |
| Coexpression | GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN | 6.74e-05 | 198 | 91 | 6 | M7228 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN | 6.74e-05 | 198 | 91 | 6 | M4981 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 6.93e-05 | 199 | 91 | 6 | M1466 | |
| Coexpression | GSE27786_BCELL_VS_ERYTHROBLAST_DN | 7.12e-05 | 200 | 91 | 6 | M4811 | |
| Coexpression | GSE17721_LPS_VS_CPG_16H_BMDC_UP | 7.12e-05 | 200 | 91 | 6 | M4007 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP | 7.12e-05 | 200 | 91 | 6 | M8853 | |
| Coexpression | GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP | 7.12e-05 | 200 | 91 | 6 | M4301 | |
| Coexpression | LIAO_METASTASIS | 1.10e-04 | 540 | 91 | 9 | M13809 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 1.12e-04 | 217 | 91 | 6 | MM1156 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_7_DN | 1.18e-04 | 5 | 91 | 2 | M2181 | |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_UP | 1.29e-04 | 223 | 91 | 6 | M11383 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | KAT8 UBAC1 MAZ RBM42 SLTM SHARPIN SMARCC1 PUM2 RSRC2 PBX2 SNRPB HNRNPD THAP11 | 1.39e-04 | 1129 | 91 | 13 | M42508 |
| Coexpression | DESCARTES_ORGANOGENESIS_INHIBITORY_INTERNEURONS | 1.54e-04 | 30 | 91 | 3 | MM3663 | |
| Coexpression | LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED | 1.54e-04 | 30 | 91 | 3 | M39220 | |
| Coexpression | PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP | 1.67e-04 | 79 | 91 | 4 | M3737 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | KAT8 UBAC1 MAZ RBM42 SLTM SHARPIN SMARCC1 PUM2 RSRC2 PBX2 SNRPB HNRNPD THAP11 | 1.78e-04 | 1158 | 91 | 13 | MM1338 |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP | 1.87e-04 | 32 | 91 | 3 | M1930 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_500 | 2.15e-06 | 89 | 90 | 6 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | IRS4 FOXQ1 KCNA4 SPOCK3 ASXL3 SLTM PUM2 ASXL2 SIX4 RSRC2 PBX2 KLF4 KDM6A HMGCLL1 HNRNPD | 2.67e-06 | 850 | 90 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.82e-07 | 200 | 91 | 7 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.82e-07 | 200 | 91 | 7 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.82e-07 | 200 | 91 | 7 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.37e-07 | 145 | 91 | 6 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-06 | 175 | 91 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.61e-06 | 175 | 91 | 6 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 181 | 91 | 6 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 2.02e-06 | 182 | 91 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-06 | 183 | 91 | 6 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-06 | 185 | 91 | 6 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.29e-06 | 186 | 91 | 6 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-06 | 190 | 91 | 6 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-06 | 190 | 91 | 6 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.84e-06 | 193 | 91 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.92e-06 | 194 | 91 | 6 | 4e93bd903cddfd0c8f220b6a35b449895de4119b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.48e-06 | 200 | 91 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-06 | 200 | 91 | 6 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 5.42e-06 | 123 | 91 | 5 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.47e-05 | 151 | 91 | 5 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.67e-05 | 155 | 91 | 5 | 79264ff283e36a059040a5aa9fe7337be694cb52 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.00e-05 | 161 | 91 | 5 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 2.00e-05 | 161 | 91 | 5 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.19e-05 | 164 | 91 | 5 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 167 | 91 | 5 | 49b19159c62d33d65ed1e59a148c11ae902fd41c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.82e-05 | 173 | 91 | 5 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB|TCGA-Thymus / Sample_Type by Project: Shred V9 | 2.98e-05 | 175 | 91 | 5 | 50f9b994bdd389158f92f891944ea81b2fb15eef | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 175 | 91 | 5 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.07e-05 | 176 | 91 | 5 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 3.07e-05 | 176 | 91 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-05 | 181 | 91 | 5 | a436e7e4c36403257ea90160a58ca0d6d7c0cdfc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 181 | 91 | 5 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.60e-05 | 182 | 91 | 5 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.60e-05 | 182 | 91 | 5 | f2a1784ffcba9b27132e0db21e574cbd8a0a6418 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.60e-05 | 182 | 91 | 5 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.60e-05 | 182 | 91 | 5 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.69e-05 | 183 | 91 | 5 | f517215ff45dec914af52dfdbc4579c19654c3aa | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.69e-05 | 183 | 91 | 5 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.89e-05 | 185 | 91 | 5 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | Control-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 3.89e-05 | 185 | 91 | 5 | d5d6d13e2f20b54ca55645b9a757b8599f4fd897 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 186 | 91 | 5 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-05 | 186 | 91 | 5 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.99e-05 | 186 | 91 | 5 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 186 | 91 | 5 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-05 | 186 | 91 | 5 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 187 | 91 | 5 | dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-05 | 187 | 91 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.09e-05 | 187 | 91 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 187 | 91 | 5 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.20e-05 | 188 | 91 | 5 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 189 | 91 | 5 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-05 | 189 | 91 | 5 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 4.31e-05 | 189 | 91 | 5 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 190 | 91 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.41e-05 | 190 | 91 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 190 | 91 | 5 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-05 | 191 | 91 | 5 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 4.64e-05 | 192 | 91 | 5 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | Control-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 4.64e-05 | 192 | 91 | 5 | f95fb188aa642f3d0618242a770e7c4b70544adb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.64e-05 | 192 | 91 | 5 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.64e-05 | 192 | 91 | 5 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-05 | 192 | 91 | 5 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 193 | 91 | 5 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 4.76e-05 | 193 | 91 | 5 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 193 | 91 | 5 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.76e-05 | 193 | 91 | 5 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 193 | 91 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.76e-05 | 193 | 91 | 5 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.76e-05 | 193 | 91 | 5 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-05 | 194 | 91 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.87e-05 | 194 | 91 | 5 | 9441202d6fa2ffbef9277d48ae9bc98876c26ec5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-05 | 194 | 91 | 5 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.87e-05 | 194 | 91 | 5 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 195 | 91 | 5 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-05 | 196 | 91 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-05 | 196 | 91 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.24e-05 | 197 | 91 | 5 | 47c4d9de71a435119c71f5219de836cf9b2aab6d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.24e-05 | 197 | 91 | 5 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.24e-05 | 197 | 91 | 5 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.24e-05 | 197 | 91 | 5 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-05 | 198 | 91 | 5 | c8272ac4d90f2367f538f66db40de911ad73ea7f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.37e-05 | 198 | 91 | 5 | 7a99c341736a4a2ac48ef8e2f7951f21a7378946 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 5.37e-05 | 198 | 91 | 5 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 5.37e-05 | 198 | 91 | 5 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-05 | 198 | 91 | 5 | 6e314dc820db9c53fe7fc7c96bed4d7d9a325160 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-05 | 199 | 91 | 5 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.50e-05 | 199 | 91 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-05 | 199 | 91 | 5 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-05 | 199 | 91 | 5 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | proximal|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.63e-05 | 200 | 91 | 5 | 33f05ed458c889bf241580f513ce66797007248c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 76e90231aa94afc12e618da8ae314c51644acab4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Interneuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 5.63e-05 | 200 | 91 | 5 | a313b9a8bde1ea80a6eae183b76fba46b86558b4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | e3e80cb16e0d2e24efc16b62316a6da91bf81ea5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.63e-05 | 200 | 91 | 5 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.63e-05 | 200 | 91 | 5 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.63e-05 | 200 | 91 | 5 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| Drug | TBPS | 1.34e-06 | 87 | 91 | 6 | CID000104781 | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Down 200; 8.6uM; HL60; HT_HG-U133A | 1.38e-05 | 196 | 91 | 7 | 2424_DN | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.48e-05 | 198 | 91 | 7 | 4064_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.53e-05 | 199 | 91 | 7 | 6771_UP | |
| Drug | MMI270 | 4.83e-05 | 18 | 91 | 3 | CID000446504 | |
| Drug | valerate | 5.60e-05 | 102 | 91 | 5 | CID000007991 | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.16e-04 | 190 | 91 | 6 | 4322_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; HL60; HT_HG-U133A | 1.16e-04 | 190 | 91 | 6 | 6156_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 1.19e-04 | 191 | 91 | 6 | 1665_UP | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.22e-04 | 192 | 91 | 6 | 4356_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 1.22e-04 | 192 | 91 | 6 | 1634_UP | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.26e-04 | 193 | 91 | 6 | 2093_UP | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 194 | 91 | 6 | 3316_DN | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 1.29e-04 | 194 | 91 | 6 | 4310_UP | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 194 | 91 | 6 | 2891_DN | |
| Drug | ibotenic acid | 1.31e-04 | 122 | 91 | 5 | CID000001233 | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.33e-04 | 195 | 91 | 6 | 6039_UP | |
| Drug | Methiazole; Up 200; 15uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 3796_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 4307_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 3996_UP | |
| Drug | Trioxsalen [3902-71-4]; Up 200; 17.6uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 5736_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 5871_UP | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.37e-04 | 196 | 91 | 6 | 7300_UP | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 2128_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 4120_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 4134_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 6043_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 2892_DN | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; PC3; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 7153_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 1.41e-04 | 197 | 91 | 6 | 2768_DN | |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 6363_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 3680_DN | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 2170_UP | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 6395_DN | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 5690_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; HL60; HT_HG-U133A | 1.45e-04 | 198 | 91 | 6 | 2191_DN | |
| Drug | Felbinac [5728-52-9]; Up 200; 18.8uM; HL60; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 3061_UP | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 1683_DN | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 3580_UP | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 5994_UP | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 6092_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 5817_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.49e-04 | 199 | 91 | 6 | 7348_UP | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.53e-04 | 200 | 91 | 6 | 6329_UP | |
| Disease | osteopetrosis (implicated_via_orthology) | 8.59e-07 | 7 | 87 | 3 | DOID:13533 (implicated_via_orthology) | |
| Disease | Dent disease (implicated_via_orthology) | 2.57e-05 | 3 | 87 | 2 | DOID:0050699 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 2.38e-04 | 8 | 87 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_marker_for) | 2.71e-04 | 301 | 87 | 6 | DOID:684 (is_marker_for) | |
| Disease | tauopathy (implicated_via_orthology) | 3.81e-04 | 10 | 87 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | photoreceptor cell layer thickness measurement | 9.79e-04 | 148 | 87 | 4 | EFO_0803370 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 1.28e-03 | 18 | 87 | 2 | C0342384 | |
| Disease | glaucoma (is_marker_for) | 1.58e-03 | 20 | 87 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Renal glomerular disease | 2.09e-03 | 23 | 87 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.09e-03 | 23 | 87 | 2 | C4521256 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 2.42e-03 | 90 | 87 | 3 | DOID:11832 (biomarker_via_orthology) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 2.67e-03 | 26 | 87 | 2 | DOID:234 (is_implicated_in) | |
| Disease | Kallmann Syndrome | 2.67e-03 | 26 | 87 | 2 | C0162809 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVSAAALVSGGVAQA | 41 | Q8NHY2 | |
| GAASAAINASVGAAG | 156 | Q15758 | |
| AINASVGAAGSAENA | 161 | Q15758 | |
| TAAATAAAVSPAAAG | 931 | Q4VCS5 | |
| SVESAVADALGAAGV | 881 | Q8NHU2 | |
| SEASGFAGAAREVVA | 36 | Q9NXG0 | |
| ASGAGDSAPVAAASV | 841 | Q86V15 | |
| EGAAAAAAAAGESSQ | 1661 | Q86V15 | |
| GVTAAAAAAAASGAA | 291 | Q03828 | |
| GASVSAAATAAAAGG | 231 | Q99490 | |
| LSAAAAAGVSVAFGA | 256 | P51793 | |
| ARAAAAAAAVASTSG | 2726 | Q9P2D1 | |
| TDAVSAADSANGSVG | 2861 | Q9P2D1 | |
| AAAAAAAAASVGGTI | 676 | Q76L83 | |
| AAAAAVAAAASIVSG | 1071 | Q9C0F0 | |
| VTTSGAGAAAAEAAE | 11 | Q13434 | |
| AGAAAAEAAETAEAV | 16 | Q13434 | |
| AAQAAAAAISVGSGG | 296 | P43699 | |
| AVVAAAAGLEEASAA | 251 | Q9BTD8 | |
| AAGLEEASAAVAVGA | 256 | Q9BTD8 | |
| EAGSTAGAAETRGAV | 246 | O75781 | |
| AQAAAAAAAGGTASS | 476 | Q8TB72 | |
| VESGVANFASSARAG | 11 | Q9C010 | |
| AEEGTAAAAAAAAAG | 21 | P56975 | |
| AAGAGNRAAVAVAVA | 56 | Q9Y5R2 | |
| EKGGGSAAAAAAAAA | 121 | P40424 | |
| AAASAAAAVVGAAGL | 241 | Q01851 | |
| EKGGGSAAAAAAAAA | 131 | P40425 | |
| SAAAAAAAAASGGGV | 136 | P40425 | |
| AAAAAAAAAVGSVGR | 226 | Q5VYV0 | |
| AAATVATDLESGGAG | 66 | O43474 | |
| GAAAGAAAAAVSVAA | 11 | Q6ZMT4 | |
| VAAEGAAAAATAAGG | 16 | P46095 | |
| AAEAVAAAVGTGATT | 791 | P46821 | |
| QAGVAAAASLVSVDG | 546 | O60299 | |
| AAASLVSVDGEAEAG | 551 | O60299 | |
| RGEAVAASGAAAAAA | 11 | Q8N128 | |
| MAATAAEAVASGSGE | 1 | Q9NWT6 | |
| VAAAVASAAAAQEVG | 2971 | Q9UKN7 | |
| ATGGIKEAAAAGAAA | 271 | Q8IYT1 | |
| KEAAAAGAAAGAATG | 276 | Q8IYT1 | |
| MAAQGAAAAVAAGTS | 1 | Q9H7Z6 | |
| AAAAVAAGTSGVAGE | 6 | Q9H7Z6 | |
| VSLATAAAAAAAFGD | 6 | O15550 | |
| RDFVSAGAAAGVSAA | 286 | P51798 | |
| RAAAATDTAAGAGGA | 16 | P29122 | |
| GAAAVAAGGVVTTTA | 256 | P56270 | |
| CSGIASAAAAAVEAA | 111 | Q15274 | |
| AVSTAEASRGAAAGF | 26 | Q6ZMK1 | |
| GAAAGAGAAVTSAAA | 16 | Q86XP1 | |
| NSAAASGVLAAVAAG | 301 | Q9UNW9 | |
| GAASTSAAAMATVGE | 66 | O15265 | |
| GAASAAAALVVDSDA | 191 | Q5VST9 | |
| ATNAEVSAAAAGATG | 31 | Q9NV92 | |
| AAAVAAAAAAAATGG | 91 | Q12778 | |
| AAGTAAASANGAAIK | 251 | P49918 | |
| EVLSAAAAAGVSVAF | 311 | P51795 | |
| AAAAAEAGAASGEQA | 201 | P29966 | |
| TGAVAAAAAAAVATE | 271 | Q96QS3 | |
| AAAAAAVATEGGELS | 276 | Q96QS3 | |
| RGDGTFVDAAASAGV | 271 | Q9NQ79 | |
| SQAEGAAGAAAATEK | 691 | Q6ZRV2 | |
| AGAAAAAGVESTEAE | 1041 | Q9BYK8 | |
| SSGASVAAAAAAAVA | 221 | Q14839 | |
| NEVVAVGGAAAKASS | 331 | O75056 | |
| AAADGVALGAAASTS | 156 | Q9NUM3 | |
| GLEGTAATAAAGATA | 4281 | P21817 | |
| AATAAAGATARVVAA | 4286 | P21817 | |
| AAAAAGTAGAAGTTA | 351 | Q9UJU5 | |
| AAAAAVVAEGAEAGA | 81 | Q9C009 | |
| IGAAAAAAGFDSASA | 1146 | O14654 | |
| GAAAAAGSQAAALES | 226 | Q92570 | |
| AAAAATAAVGGSAGE | 11 | Q14103 | |
| VAATQGAAAAAGSGA | 31 | Q14103 | |
| AVAAGATEISVFGAA | 161 | Q8TB92 | |
| IAAAAATGGSVLNVA | 266 | Q7L4I2 | |
| MAEASAAGADSGAAV | 1 | Q9Y4L5 | |
| GRGTVAAAAVAATAS | 146 | P63162 | |
| AAGAATIIGSAGAAA | 216 | Q5TGY1 | |
| RGGDAAAAVAAVVAA | 11 | O75446 | |
| AVVAAAAAAASAGNG | 21 | O75446 | |
| EAAPAAGEASSAAAA | 101 | Q6T4R5 | |
| SQADGSVAAGVDAAE | 526 | Q9ULZ9 | |
| MAAATGAVAASAASG | 1 | Q9NWH9 | |
| GAVAASAASGQAEGK | 6 | Q9NWH9 | |
| AAARVSGEEGAVAAA | 61 | Q9UIU6 | |
| GGAAAAASDLGSAAV | 6 | Q9H0F6 | |
| GRGTVAAAAAAATAS | 146 | P14678 | |
| ASLAAGAATGAVETG | 26 | P29371 | |
| AASVALAVAAGAQDS | 6 | P47972 | |
| FADGSAVVQSGDTAV | 66 | Q8TCS8 | |
| SAASAFAIATAGANE | 901 | Q13972 | |
| ATGSGIAAAAAGLAV | 16 | Q92922 | |
| AEAAAATAVVGFGSS | 341 | P29508 | |
| AAAAASAGGKEAASG | 466 | P0CG40 | |
| AAAAAAAVAGGEQQT | 46 | P28702 | |
| SFGGSDEEAAAAAAA | 331 | Q8N2M8 | |
| AAAAAAAASGVTTGK | 341 | Q8N2M8 | |
| ASVGATSGLVEAAAV | 286 | Q9Y330 | |
| TRAAAGEEETAAAGS | 36 | Q9NS37 | |
| ESAAAAAAAAAGTPV | 331 | Q9H8N7 | |
| AAAAAVAAAGGRSDG | 21 | Q9BQ16 | |
| AVSEAGASGITEAQA | 581 | O94901 | |
| GATAAASEAAAGASA | 251 | Q9BSL1 | |
| GAAAAAAASELQAAT | 201 | Q96EK4 | |
| AAAVAAATAAVEGSG | 41 | P22459 | |
| TASGTVAAEETGAAA | 131 | Q496Y0 | |
| VAAEETGAAAAAAAT | 136 | Q496Y0 |